(France) July 23rd, 2020 – As part of the Coalition Innovation Santé – Crise Sanitaire initiative, Chronolife
and Servier are collaborating to accelerate the deployment of a non-invasive
telemonitoring solution which aims to facilitate remote monitoring of chronic
patients during the COVID-19 pandemic and enable
healthcare professionals to provide better patient care.
the Covid-19 pandemic, hospital bed occupancy rates in intensive care units were
Paris, le 23 juillet 2020 – Chronolife
et Servier s’associent dans le cadre de l’initiative Coalition Innovation Santé
– Crise Sanitaire pour accélérer le déploiement d’une solution de
télésurveillance non invasive qui vise à améliorer le suivi à distance des patients souffrant de maladies
chroniques, en période de crise Covid-19, et à faciliter leur prise en charge par les
professionnels de santé.
Pendant la période de pandémie du Covid-19, Read more
Paris, 28, 2020 /PRNewswire/ — Chronolife, an artificial intelligence company specializing in digital health, today announced that it has secured Class IIa medical certification from the European Union for its groundbreaking medical-grade smart T-shirt, KeeSense™. The multi-sensor wearable device continuously monitors electrocardiography (ECG), thoracic respiration, abdominal respiration, skin temperature, thoracic impedance, and physical activity, enabling healthcare practitioners to remotely track vital clinical data about their patients. The platform’s receipt of a medical Conformité Européenne (CE) mark allows KeeSense™ Read more
Chronolife’s innovative T-shirt-based platform captures biometrics to track chronic conditions such as heart disease
LONDON, U.K. — December 5, 2019 Read more
Based on an in-depth analysis of the global predictive health analytics and monitoring market, Frost & Sullivan recognizes Chronolife, a pioneer in the wearable biometrics space, with the 2019 Global Visionary Innovation Leadership Award. Chronolife’s innovative clothing-integrated bio-sensing platform combines artificial intelligence (AI) with an accessible form factor to monitor and predict medical events in real time.
Paris, France, 03 July 2019 – Chronolife, an artificial intelligence company specialized in digital health with a patented edge computing technology and algorithm named HOTS, receives CE (Conformité Européenne) marking in addition to FCC (Federal Communications Commission) certification for its Nexkin monitoring solution. Chronolife has also announced that it will collaborate with BePatient, specialized in e-health solutions.
The Nexkin solution developed by Chronolife includes a comfortable multi-sensory T-shirt that collects, stores, Read more
Paris (France), March 22, 2019 – Chronolife, an artificial intelligence company specialized in digital health, received special honors in the start-up category of the French award “Trophées de l’embarqué et des objets connectés”.
The 3rd edition of the “Trophées de l’embarqué et des objets connectés” (Embedded and Smart objects awards), organized in cooperation with the Electroniques magazine and the MtoM & Objets Connectés – Embedded Systems show, took place on March 20th, Read more
Paris (France), March 12, 2019 – Chronolife, an artificial intelligence company specialized in digital health, announced the appointment of Dr. Zarifah Reed as Chief Medical Officer. In this role, Dr Reed will oversee the clinical development of Chronolife’s predictive and innovative solution for detection & prediction of worsening heart failure.
Chronolife’s predictive solution comprises of a washable T-Shirt capable of continuously collecting, storing and transmitting data, a smartphone application that receives, Read more
Paris (France), January 6th, 2019 – Chronolife, an artificial intelligence company specialized in digital health, announces the launch of the industrialization and production of its connected and washable T-shirt targeting pharma companies, insurance companies and preventive care service providers.
The company recently finalized the development of a washable T-shirt that continuously monitors and collects data on six physiological parameters (electrocardiogram, abdominal breathing, thoracic breathing, pulmonary impedance, physical activity and body temperature). Read more
Paris (France), November 21, 2018
Chronolife is pleased to announce the appointment of Laurent Vandebrouck to the role of Chief Executive Officer. This start-up co-founded in November 2015 and funded by iBionext is an artificial intelligence company specialized in digital health. Chronolife is currently developing a unique solution which continuously monitors multiple parameters and capable of detecting specific changes in patient’s health.
Before joining Chronolife, Laurent was Managing Director of Qualcomm Life Europe, Read more